INOSIPLEX THERAPY IN SUBACUTE SCLEROSING PANENCEPHALITIS
Open Access
- 1 May 1982
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 319 (8280), 1034-1037
- https://doi.org/10.1016/s0140-6736(82)92097-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Long‐term follow‐up of patients with subacute sclerosing panencephalitis treated with inosiplexAnnals of Neurology, 1982
- Review of 38 cases of subacute sclerosing panencephalitis: Effect of amantadine on the natural course of the diseaseAnnals of Neurology, 1980
- The comparative effects of isoprinosine, levamisole, muramyl dipeptide and SM1213 on lymphocyte and macrophage proliferation and activation in vitroInternational Journal of Immunopharmacology, 1979
- Suppressor cell activity after isoprinosine treatment of lymphocytes from normal miceInternational Journal of Immunopharmacology, 1979
- Epidemiology of subacute sclerosing panencephalitisThe Journal of Pediatrics, 1979
- Differntiation and Regulation of Lymphocyte Populations: Evidence for Immunopotentiator-Induced T Cell RecruitmentJournal of Immunopharmacology, 1979
- Isoprinosine as an ImmunopotentiatorJournal of Immunopharmacology, 1979
- Subacute schlerosing panencephalitis in the middle east: Report of 99 casesAnnals of Neurology, 1977
- Antiviral activity of isoprinosine in vitro and in vivoThe American Journal of the Medical Sciences, 1973
- MEASLES AS AN INDEX OF IMMUNOLOGICAL FUNCTIONThe Lancet, 1968